News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Conference News HRS 2021 Catheter Ablation ‘Good Value’ in CABANA Economic Analysis Michael O'Riordan August 04, 2021
News Conference News EHRA 2021 STROKESTOP: Small Clinical Benefit Seen With Systematic AF Screening Todd Neale April 26, 2021
News Daily News Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows Michael O'Riordan March 31, 2017